Abu Dhabi: In an ongoing effort to find innovative solutions to the challenges presented by the COVID-19 pandemic, Mubadala Healthcare has reached out to NYU Abu Dhabi (NYUAD) to utilize its 3D printing and Core Technology Platform capabilities to meet the growing demand for critical medical supplies.

The aim of Mubadala Healthcare’s initiative is to act proactively by meeting immediate needs, but in a sustainable way. The new 3D printed masks will be similar to the top-rated N95 mask, but reusable and with replacement filters.

Hasan Jasem Al Nowais, Senior Vice President at Mubadala Healthcare, says: “This collaboration is aligned with Mubadala Investment Company’s #WeAreDedicated campaign, launched as a COVID-19 response strategy to find ways to collaborate across diverse enterprises and sectors to protect the community, and support the UAE government in its efforts to tackle the pandemic and mitigate its impacts. We were impressed by the enthusiastic response we received from all parties involved and the speed at which development has taken place.”

“While our own facilities are well placed to procure supplies today, it is important to have a more robust and diversified supply network moving forward. It is our hope that our work will also help to ensure adequate supply to meet the UAE’s needs, and that our methods can help the international community as well.”

For the 3D-printing mask project, Mubadala Healthcare has enlisted the experts at its Cleveland Clinic Abu Dhabi facility to advise on issues regarding supply chain and clinical engineering, as well as seeking their medical opinion and help in testing the equipment.

NYUAD was able to respond immediately to Mubadala Healthcare’s call, working with the project team and using its substantial resources in 3D printing, engineering, and design to turn around physical prototypes in less than 48 hours.

The prototypes are currently being tested in non-live conditions by the Cleveland Clinic Abu Dhabi physicians, and after receiving feedback, the University will optimize the design of the masks.

NYU Abu Dhabi Vice Provost for Innovation and Managing Director of startAD Ramesh Jagannathan said: “We are continually seeking ways to support COVID-19 solutions, and protecting the country’s healthcare workers should be one of the top priorities. This initiative allows us to directly contribute to the government’s response to the outbreak, and builds on our existing role of offering the highest standards in education. I am proud to say that two members of the team at Mubadala Healthcare working on this project are NYUAD alumni.”

Jagannathan explains that the 3D printed prototypes are designed to meet the performance standards of the N95 mask, but enhanced by the fact that the modular new design will enable the masks to be sterilized and reused, with removable, replaceable filters.

Mubadala Healthcare’s Al Nowais emphasizes that this project is part of Mubadala Healthcare’s broader approach to responding proactively to the pandemic. Among other steps, it has already established on-site and drive-through screening centers at its facilities, increased laboratory testing capacity for COVID-19, launched pharmacy home delivery, and expanded telemedicine across assets.

“We will continue to work with other Mubadala assets as well as highly regarded external parties in an ongoing effort to support the UAE leadership and its people to overcome the current challenges wherever possible,” he concludes. 

-Ends-

About Mubadala Investment Company

Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for its shareholder, the Government of Abu Dhabi.

Mubadala’s US $229 billion portfolio spans five continents with interests in multiple sectors including aerospace, ICT, semiconductors, metals and mining, renewable energy, oil and gas, petrochemicals, utilities, healthcare, real estate, pharmaceuticals and medical technology, agribusiness and a global portfolio of financial holdings across all asset classes. Mubadala has offices in Rio de Janeiro, Moscow, New York, San Francisco, and London.

Mubadala is a trusted partner, an engaged shareholder and a responsible global company that is committed to world-class standards of governance. 

Media Contacts
Salma Chalak, Consultant, Wallis PR
Telephone: +071 58 982 9525
Email: salma.chalak@wallispr.com 

About NYU Abu Dhabi

NYU Abu Dhabi is the first comprehensive liberal arts and science campus in the Middle East to be operated abroad by a major American research university. NYU Abu Dhabi has integrated a highly-selective liberal arts, engineering and science curriculum with a world center for advanced research and scholarship enabling its students to succeed in an increasingly interdependent world and advance cooperation and progress on humanity’s shared challenges. NYU Abu Dhabi’s high-achieving students have come from more than 115 nations and speak over 115 languages. Together, NYU's campuses in New York, Abu Dhabi, and Shanghai form the backbone of a unique global university, giving faculty and students opportunities to experience varied learning environments and immersion in other cultures at one or more of the numerous study-abroad sites NYU maintains on six continents.


Send us your press releases to pressrelease.zawya@refinitiv.com 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.